Los Angeles, California (CA) Biological Products, Except Diagnostic Companies

Featured companies
Bachem California
3132 Kashiwa St.
Torrance CA 90505
(310) 539-4171
Cytrx Corporation (Del)
11726 San Vicente Blvd # 650
Los Angeles CA 90049
(310) 826-5648
Grifols Biologicals Inc
5555 Valley Blvd.
Los Angeles CA 90032
(323) 225-2221
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Moorhead & Company
P.O. BOX 8092
Los Angeles CA 90008
(323) 873-6640
Weco Products Inc Pet Supls
2138 W 17th St.
Long Beach CA 90813
(562) 437-7269
Moorhead & Company Inc
P.O. BOX 8092
Van Nuys CA 91409
(818) 787-2510
Autoimmune Inc
1199 Madia St.
Pasadena CA 91103
(626) 792-1235
Impact Diagnostics Intl
748 E Bonita Ave # 211
Pomona CA 91767
(909) 621-5118
Sierra For Medical Science
6327 Hoover Ave # A
Whittier CA 90601
(562) 696-5969
Martin Bio-Products
P.O. BOX 1847
Burbank CA 91507
(818) 845-8642
KVP
16018 Adelante St.
Azusa CA 91702
(626) 633-0077
Bone Clones
21416 Chase St # 1
Canoga Park CA 91304
(818) 709-7991
Superstat Corp
2015 E University Dr.
Rancho Dominguez CA 90220
(310) 537-3300
Ev International Inc
29395 Agoura Rd Ste 208
Agoura Hills CA 91301
(818) 991-2556
Whereorg has 14 results under Biological Products, Except Diagnostic Companies in Los Angeles.

Narrow down the browsing criteria below to see more companies.

Select a location for category Biological Products, Except Diagnostic


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020